FDA Cites Meta-Analysis To Validate Surrogate Endpoint for Pfizer's Revatio
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee will be asked to support the use of a hemodynamic endpoint in pediatric trials of Pfizer's Revatio (sildenafil).